ProShares UltraShort NASDAQ Biotechnology
9 hedge funds and large institutions have $1.47M invested in ProShares UltraShort NASDAQ Biotechnology in 2020 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
26% less capital invested
Capital invested by funds: $1.99M → $1.47M (-$521K)
Holders
9
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$551K | |
| 2 | +$273K | |
| 3 | +$110K | |
| 4 |
SFS
Sowell Financial Services
North Little Rock,
Arkansas
|
+$54K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$15K |
Top Sellers
| 1 | -$928K | |
| 2 | -$254K | |
| 3 | -$130K | |
| 4 |
WP
WealthSource Partners
San Luis Obispo,
California
|
-$23.5K |